As Japan IT Week 2024 concluded on 26th April, 47Billion reflects on a dynamic three-day showcase of cutting-edge technology, collaborative innovation, and visionary insights. From showcasing products to diving into…
Under Section 340B of the Public Health Service Act, pharmaceutical companies that participate in Medicaid have to offer discounts on outpatient drugs to covered entities(healthcare organizations) that serve several uninsured…
The 340B Drug Pricing Program, initiated by Congress in 1992, revolutionized access to essential medications for vulnerable populations across the United States. This program mandates pharmaceutical manufacturers to offer outpatient…
For the last several years, challenges related to geopolitics, technology, pandemic, and climate change have been impacting the manufacturing sector. They have created shifts in manufacturers' thought processes, operations, and…
Today, integrating ESG(Environmental, Social, and Governance) in Manufacturing Supply chain strategies emerges as a roadmap for sustainable growth, resilience, and competitive edge. Studies indicate that companies with robust ESG frameworks…
The 340B Program presents substantial financial advantages for eligible healthcare institutions, potentially saving millions in prescription reimbursements. Despite this potential windfall, adherence to program regulations is paramount for maximizing benefits.…
Securing a competitive edge requires action now, as upstarts are challenging the old guard at every stage. In this evolving scenario, survival requires prioritization of necessary ESG(Environmental, Social, and Governance)…
The Health Resources and Services Administration (HRSA) 340B program plays a vital role in expanding access to affordable medications for eligible patients. To ensure compliance with program requirements, covered entities…
What are the most significant roadblocks for healthcare organizations participating in the 340B program? As per a study, more than 60 healthcare providers are participating in the 340B Drug Pricing…
As the global AI market propels towards a projected $190.61 billion by 2025, the influence of next-generation tools like ChatGPT extends widely. While ChatGPT holds transformative potential, it's crucial to…
